About Us

MISSION STATEMENT: The HIV+Hepatitis Policy Institute promotes quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions.

Monitors policies that impact the prevention and treatment of HIV, viral hepatitis, and other health conditions in the United States.

Communicates with members of the HIV, hepatitis, and other patient group communities on key policy issues that impact their access to healthcare.

Educates policymakers and members of the media about efforts to end both HIV and hepatitis in the United States and to improve access to quality and affordable healthcare for people with or at risk of serious or chronic health conditions.

Our Team

CARL SCHMID

Executive Director, HIV+Hepatitis Policy Institute, Washington, D.C.

cschmid@hivhep.org

Carl Schmid has been a national policy and advocacy leader in the HIV community for over 20 years.  He spent 16 years with The AIDS Institute, serving as its Deputy Executive Director. In December 2019, he formed the HIV+Hepatitis Policy Institute, which promotes quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions.

Mr. Schmid leads advocacy efforts to ensure domestic HIV and hepatitis programs are based on sound public policy and fully funded. He has expertise in healthcare financing systems, including Medicaid and Medicare, and leads efforts to ensure that the Affordable Care Act meets the needs of beneficiaries, including prescription medications.

From December 2018 to August 2021 he served as Co-Chair of the Presidential Advisory Council on HIV/AIDS (PACHA). He currently serves as a member of PACHA and as a consumer representative to the National Association of Insurance Commissioners. 

He is a cancer survivor and living with chronic hepatitis B.

Mr. Schmid earned a B.A. in Public Affairs and an M.B.A. in International Affairs from the George Washington University in Washington, D.C.

Kevin Herwig

Health Policy Manager

kherwig@hivhep.org

Scott Palmer

Executive Assistant

spalmer@hivhep.org

Ann Lefert

The Lefert Group

Policy Consultant

ann@thelefertgroup.com

Jennifer Burke

Communications Consultant

jburke@hivhep.org

Board Members

CARL SCHMID

President

Executive Director

HIV+Hep Policy Institute

Washington, DC

ANDREW SPERLING

Vice President

Senior Director, Government Affairs

Intra-Cellular Therapies, Inc.

Washington, DC

REKHA RAMESH

Treasurer 

Vice President, Head of Global Policy

Gilead Sciences, Inc.

Foster City, CA

 

JUSTIN C. SMITH MS, MPH

Secretary

Director, Campaign to End AIDS

Positive Impact Health Centers

Atlanta, GA

ERIN DARLING

Associate Vice President of Federal Policy

Merck

Washington, DC

MARC MEACHEM

Director of External Affairs

ViiV Healthcare

Washington, DC

RAFAELÉ NARVÁEZ

Co-Founder

Latinos Salud

Oakland Park, FL

PAM TRAXEL

Senior Vice President

American Cancer Society

Cancer Action Network

Washington, DC

STEVEN R. YOUNG

Former Director

HIV/AIDS Bureau, HRSA, HHS

Yardley, PA

Funders for HIV+Hepatitis Policy Institute

HIV+Hep appreciates the support of numerous funders, and recognizes those below that are our corporate members and sponsors:

Get Involved

Facebook posts by @HIV+Hep

Tweets by @HIV+Hep

“Insurance companies should not require patients to take medications that might have severe side effects or make their condition worse, especially when a proven treatment is available,” says @SenatorHassan #safestepact #steptherapyreform https://t.co/I1O0qwyBRx https://t.co/VazcxaxRRI HIVHep photo
The USPSTF issued an updated grade “A” #PrEP recommendation that now includes #long-acting #injectable PrEP & necessary lab testing. @HIVHep strongly supports this recommendation. Now providers need to follow it & offer #PrEP to those who can benefit: https://t.co/wjtCPBSN0j https://t.co/aROoBzdnUD HIVHep photo
@HIVHep @AutoimmuneAssoc & 48 patient orgs commented to @CMSGov on ways to improve the essential health benefits system by prohibiting #insurers from designating #Rx non-essential or taking them off-formulary & requiring patients to seek alternate funding: https://t.co/Uu4pygXwvJ https://t.co/lc6RzGb9vI HIVHep photo
Today, I’m reintroducing my National Black HIV/AIDS Awareness Day resolution to raise awareness to the disproportionate impact of HIV on Black communities.

Together, we can end HIV stigma, discrimination, and criminalization and achieve the first AIDS-free generation. https://t.co/xCm0yX9E1e
HIVHep photo
Mayor Bowser and DC Health Highlight Resources for Residents on Black HIV/AIDS Awareness Day | doh https://t.co/5QIDfISkkl

Pin It on Pinterest

Share This